Atrion (Atrion) Institutional Ownership : 46.77% (As of Apr. 25, 2024)

View and export this data going back to 1972. Start your Free Trial

What is Atrion Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Atrion's institutional ownership is 46.77%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Atrion's Insider Ownership is 13.91%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Atrion's Float Percentage Of Total Shares Outstanding is 54.10%.

Atrion Institutional Ownership Historical Data

The historical data trend for Atrion's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrion Institutional Ownership Chart

Atrion Historical Data

The historical data trend for Atrion can be seen below:

	2023-05-31	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	46.67	47.47	47.52	47.48	47.55	45.62	45.57	46.81	46.81	46.77

Atrion Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Atrion (Atrion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atrion Corp (NAS:ATRI) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Allentown Parkway, Allen, TX, USA, 75002-4211

Website

https://www.atrioncorp.com

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

Executives

Preston G Athey	director	ONE ALLENTOWN PKWY, ALLEN TX 75002
David A Battat	officer: President & CEO	2700 HALKEY-ROBERTS PLACE NORTH, ST. PETERSBURG FL 33716-4103
Jeannette Bankes	director	ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Morgan Hugh J Jr	director
Ronald Nicholas Spaulding	director	ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Cindy Ferguson	officer: Officer/ CFO	ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffery Strickland	officer: Vice President & CFO
Emile A Battat	director, officer: Chairman	ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Stupp John P Jr	director	STUPP JOHN P JR, #18 ST. ANDREWS DR., ST LOUIS MO 63124
Roger F Stebbing	director
Ronald N Spaulding	director	C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Richard O Jacobson	director	ONE ALLENTOWN PARKWAY, C/O ATRION, ALLEN TX 75002
Maley John H P	director	6 ROCK CREST LANE, SIGNAL MOUNTAIN TN 37377
Margaret Maxwell Zagel	director	C/O TELLABS OPERATIONS INC, 4951 INDIANA AVE, LISLE IL 60532